Suchergebnisse - "Usmani, Saad Z"

PubPharm (32)

1

BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy

enthalten in: Drugs | 2022

von Paul, B. | Rodriguez, C. | Usmani, S.

2

Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician’s Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

enthalten in: Clinical drug investigation | 2021

von Weisel, K. | Martin, T. | Krishnan, A. | +14

3

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

enthalten in: Annals of hematology | 2021

von Iida, S. | Ishikawa, T. | Min, C. | +12

4

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

enthalten in: Journal of cancer research and clinical oncology | 2020

von Usmani, S. | Mateos, M. | Hungria, V. | +16

5

Extramedullary Disease in Multiple Myeloma

enthalten in: Current hematologic malignancy reports | 2020

von Jagosky, M. | Usmani, S.

6

Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses

enthalten in: Advances in therapy | 2020

von Xu, X. | Moreau, P. | Usmani, S. | +13

7

Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison

enthalten in: American journal of hematology | 2017

von Usmani, S. | Diels, J. | Ito, T. | +3

8

The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy

enthalten in: Clinical advances in hematology & oncology : H&O | 2016

von Voorhees, P. | Usmani, S.

9

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

enthalten in: The lancet | 2016

von Lonial, S. | Weiss, B. | Usmani, S. | +29

10

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

enthalten in: Leukemia & lymphoma | 2016

von Bhutani, M. | Turkbey, B. | Tan, E. | +19